Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Purpose: The present study aims to evaluate a set of oxidative stress biomarkers in the amniotic fluid (AF) of women carrying Down syndrome (DS) fetuses that could prove in vivo the early occurrence of oxidative damage in DS. Experimental design: To assess the extent of protein oxidation in DS AF, we measured protein carbonylation and protein‐bound HNE by slot‐blot analysis, total and oxidized GSH levels by enzymatic assay and heat shock proteins (HSPs) thioredoxin (Trx) induction by Western blot. Further, by a redox proteomics approach specific targets of protein carbonylation were identified. Results: We found increased levels of oxidative stress, as indexed by increased protein oxidation, lipid peroxidation, reduction of GSH and Trx levels and induction of the HSP response. By a redox proteomics approach, we identified selective proteins which showed increased oxidation in DS fetuses compared with healthy controls. The identified proteins are involved in iron homeostasis (ceruloplasmin and transferin), lipid metabolism (zinc‐α2‐glycoprotein, retinol‐binding protein 4 and apolipoprotein A1) and inflammation (complement C9, α‐1B‐glycoprotein, collagen α‐1V chain) with critical relevance in the clinical outcome of DS. Conclusions and clinical relevance: Our results indicate that oxidative damage is an early event in the DS pathogenesis and might contribute to the development of deleterious DS phenotypes, including abnormal development and AD‐like neuropathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased oxidative damage occurs early in DS development, as evidenced by the fact that neurons obtained from aborted fetuses with DS show evidence of increased oxidative damage63 as does amniotic fluid from mothers carrying fetuses with DS64.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [63]
Citations
Cites
[37] Carbonyl assays for determination of oxidatively modified proteins
Levine, R. L., Williams, J. A., Stadtman, E. P., & Shacter, E. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,699 · cited 1×
“[17].”
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · cited 1×
“[32] suggested that OS in fetal DS results from low levels of reducing agents, rather than of SOD-1 overexpression [33].”
BackgroundBiochemistry of oxidative stress
Halliwell, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351147 · Cited by 1,543 · cited 1×
“Once formed, this compound can react with reduced form of redox-active transition metal ions, producing the dangerous oxidant, hydroxyl radical [8] that causes oxidative damage to biological macromolecules.”
BackgroundRetinol-binding protein: the transport protein for vitamin A in human plasma
Kanai, M., Raz, A., & Goodman, D. S. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105889 · Cited by 899 · cited 1×
“[58] It is mainly produced in the liver but has recently been identified as an adipokine [59], which is able to modulate glucose metabolism.”
BackgroundApoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741 · cited 1×
“In addition, DS neurons exhibit a consistent increase in intracellular ROS and elevated levels of lipid peroxidation that precede neuronal death [26].”
BackgroundBains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 717
Colman, R. W., & Schmaier, A. H. (1997) · Blood · doi:10.1182/blood.v90.10.3819 · Cited by 581 · cited 1×
“Through these interactions, HK modulates cellular adhesion, leukocyte extravasation and vascular permeability [68, 69].”
BackgroundInsulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions
Lee, P. D. K., Giudice, L. C., Conover, C. A., & Powell, D. R. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44182 · Cited by 523 · cited 1×
“IGFBP-1 regulates minute-to-minute bioavailability of IGFs in the circulation and inhibits IGF actions [50].”
BackgroundLauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · cited 1×
“The IP was performed as described previously [24].”
MethodSelf-citationLassarre, C., Hardouin, S., Daffos, F., Forestier, F., Frankenne, F., & Binoux, M. (1991) · Pediatric Research · doi:10.1203/00006450-199103000-00001 · Cited by 411 · cited 1×
“IGFs are a family of mitogenic polypeptides that have been shown to be important determinants of fetal growth during human pregnancy[51–53].”
Background
Research works printed but not linked: 2
- 10.1089/ars.2004.6.878 · doi:10.1089/ars.2004.6.878 · Paper page
- 10.1002/1522-2683()22:6<1233::aid-elps1233>3.0.co;2-m · doi:10.1002/1522-2683()22:6<1233::aid-elps1233>3.0.co;2-m
Cited by
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Self-citationButterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403
“Oxidative stress occurs extremely early in DS [165]: we reported that amniotic fluid of mothers carrying DS fetuses show increased oxidative stress, and redox proteomics identified oxidatively modified proteins in amniotic fluid that are consistent with the spectrum of phenotypes associated with DS [166].”
ResultSelf-citationCellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
“Furthermore, mitochondrial dysfunction is also present in DS cells during embryonic life (Perluigi et al., 2011), leading to profound alterations in energy metabolism due to the reduced synthesis of ATP synthesis (Valenti et al.”
BackgroundPerluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
Self-citationOxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
“The identified proteins are involved in iron homeostasis (ceruloplasmin and transferin), lipid metabolism (Zinc-alpha2-glycoprotein, retinol binding protein 4 and Apolipoprotein A1), and inflammation (Complement C9, Alpha-1B-glycoprotein, Collagen alpha-1 V chain) with critical relevance in the clinical outcome of DS…”
BackgroundSelf-citationRedox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Perluigi, M., Reed, T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Sultana, R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 168
“Moreover, amniotic fluid from mothers carrying a DS fetus has oxidatively modified proteins as observed by redox proteomics (301).”
Self-citationColacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167
Association of Oxidative Stress on Pregnancy
Toboła-Wróbel, K., Pietryga, M., Dydowicz, P., Napierała, M., Brązert, J., & Florek, E. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6398520 · Cited by 159
“[39] (Italy) Protein carbonylation Protein-bound HNE Reduced glutathione (GSH)”
BackgroundNeuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
Perluigi, M., Pupo, G., Tramutola, A., Cini, C., Coccia, R., Barone, E., Head, E., Butterfield, D. A., & Di Domenico, F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.007 · Cited by 155
Self-citationDi Domenico, F., Coccia, R., Cocciolo, A., Murphy, M. P., Cenini, G., Head, E., Butterfield, D. A., Giorgi, A., Schinina, M. E., Mancuso, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.013 · Cited by 134
Self-citationCenini, G., Dowling, A. L. S., Beckett, T. L., Barone, E., Mancuso, C., Murphy, M. P., LeVine, H., Lott, I. T., Schmitt, F. A., Butterfield, D. A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.001 · Cited by 123
“A recent study showed that amniotic fluid from mothers carrying DS fetuses had significantly elevated markers of oxidation [60].”
Self-citationButterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126
“had elevated indices of oxidative stress and increased oxidative modification of key proteins such as apolipoprotein A1 [80].”
BackgroundSelf-citationVerrastro, I., Pasha, S., Jensen, K., Pitt, A., & Spickett, C. (2015) · Biomolecules · doi:10.3390/biom5020378 · Cited by 114
“Using such approaches, evidence of increased levels of protein carbonyls have been detected in tissues from patients Alzheimer’s disease [132,150,154,161], and in aged rat skeletal muscle with quantification by iTRAQ based-methods [153].”
Mass spectrometry and redox proteomics: Applications in disease
Butterfield, D. A., Gu, L., Domenico, F. D., & Robinson, R. A. S. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21374 · Cited by 115
“In a redox proteomics study on amniotic fluid from mothers carrying a DS fetus specific oxidation of a number of proteins has been observed (Perluigi et al., 2011).”
BackgroundSelf-citationButterfield, D. A., Di Domenico, F., Swomley, A. M., Head, E., & Perluigi, M. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 113
Self-citationDierssen, M., Fructuoso, M., Martínez de Lagrán, M., Perluigi, M., & Barone, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00670 · Cited by 101
Mitochondria as pharmacological targets in Down syndrome
Valenti, D., Braidy, N., Rasmo, D. D., Signorile, A., Rossi, L., Atanasov, A. G., Volpicella, M., Henrion‐Caude, A., Nabavi, S. M., & Vacca, R. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.014 · Cited by 104
Domenico, F. D., Pupo, G., Tramutola, A., Giorgi, A., Schininà, M. E., Coccia, R., Head, E., Butterfield, D. A., & Perluigi, M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.027 · Cited by 100
Self-citationThe role of oxidative stress in Rett syndrome: an overview
De Felice, C., Signorini, C., Leoncini, S., Pecorelli, A., Durand, T., Valacchi, G., Ciccoli, L., & Hayek, J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06611.x · Cited by 95
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
Lanzillotta, C., Greco, V., Valentini, D., Villani, A., Folgiero, V., Caforio, M., Locatelli, F., Pagnotta, S. E., Barone, E., Urbani, A., et al. (2020) · Antioxidants · doi:10.3390/antiox9111112 · Cited by 86
Exosomal biomarkers in Down syndrome and Alzheimer's disease
Hamlett, E. D., Ledreux, A., Potter, H., Chial, H. J., Patterson, D., Espinosa, J. M., Bettcher, B. M., & Granholm, A.-C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.028 · Cited by 76
miRNA-155 upregulation and complement factor H deficits in Down’s syndrome
Li, Y. Y., Alexandrov, P. N., Pogue, A. I., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J. (2012) · NeuroReport · doi:10.1097/wnr.0b013e32834f4eb4 · Cited by 76
“This elevation may be due to inter-genetic or epigenetic effects; alternately, miRNA-155 is under the regulatory control of the transcription factor NF-κB which is also up-regulated in Down’s tissues [7,21–25].”
InfluentialDi Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., Blarzino, C., Schmitt, F. A., Head, E., Butterfield, D. A., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141254 · Cited by 75
“Trisomy of HSA21 likely increases levels of the proteins involved in redox homeostasis such as SOD-1 that when overexpressed could promote increased levels of OS, as observed in DS [3, 7, 11, 47, 78, 79].”
Self-citationApolipoprotein A‐I: Insights from redox proteomics for its role in neurodegeneration
Keeney, J. T. R., Swomley, A. M., Förster, S., Harris, J. L., Sultana, R., & Butterfield, D. A. (2013) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201200087 · Cited by 72
“A recent study also showed a significant increase in oxidation markers in amniotic fluid of women carrying DS fetuses compared to that of women carrying chromosomally normal fetuses [117].”
BackgroundResultSelf-citationThe Role of Oxidative Stress in the Pathomechanism of Congenital Malformations
Laforgia, N., Mauro, A. D., Guarnieri, G. F., Varvara, D., Cosmo, L. D., Panza, R., Capozza, M., Baldassarre, M. E., & Resta, N. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7404082 · Cited by 76
“In an effort to better understand the role of oxidative stress in DS, a set of oxidative biomarkers were evaluated in amniotic fluid collected from ten women undergoing amniocentesis and carrying confirmed DS fetuses compared with ten women carrying normal fetuses in a retrospective matched case control study [38].”
MethodCirculating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits
Domenico, F. D., Coccia, R., Butterfield, D. A., & Perluigi, M. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.001 · Cited by 73
“By following this approach, we were able to successfully identify an increased number of proteins after depletion of albumin and IgG in amniotic fluid from women carrying Down syndrome fetus compared with healthy controls [90].”
BackgroundSelf-citationDomenico, F. D., Tramutola, A., Barone, E., Lanzillotta, C., Defever, O., Arena, A., Zuliani, I., Foppoli, C., Iavarone, F., Vincenzoni, F., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101162 · Cited by 69
Self-citationGimeno, A., García‐Giménez, J. L., Audí, L., Torán, N., Andaluz, P., Dasí, F., Viña, J., & Pallardó, F. V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.014 · Cited by 65
Perluigi, M., Di Domenico, F., & Buttterfield, D. A. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300066 · Cited by 59
“The ten proteins identified with increased carbonylation in AF of a DS fetus carrying mother compared to that of normal pregnancies [114] included ceruloplasmin, serotransferrin, complement component C9, a-1Bglycoprotein, kininogen-1, zinc-a-2-glycoprotein, C -2 and C -5, insulin-like growth factor-binding protein 1 (…”
BackgroundMethodResultSelf-citationPrenatal Hypoxia and Placental Oxidative Stress: Insights from Animal Models to Clinical Evidences
Silvestro, S., Calcaterra, V., Pelizzo, G., Bramanti, P., & Mazzon, E. (2020) · Antioxidants · doi:10.3390/antiox9050414 · Cited by 67
Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases
Butterfield, D. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179912 · Cited by 55
Self-citationRodríguez-Sureda, V., Vilches, Á., Sánchez, O., Audí, L., & Domínguez, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/509241 · Cited by 54
“The effects of OS in DS from embryonic life onwards have been documented; a study that evaluated OS biomarkers in the amniotic fluid of women carrying DS fetuses indicated that oxidative damage is an early event in DS pathogenesis and might contribute to the generation of deleterious DS phenotypes and abnormal develop…”
BackgroundDisturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism
Barone, E., Arena, A., Head, E., Butterfield, D. A., & Perluigi, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.009 · Cited by 58
“In agreement with the above sentences, the evaluation of protein carbonyls and HNE-bound protein adducts were significantly increased in AF from women carrying DS fetuses with respect to AF from women carrying normal foetuses, indicating that both protein and lipid peroxidation pathways were enhanced even at the fetal…”
BackgroundMethodResultInfluentialSelf-citationLiu, Z., He, C., Chen, M., Yang, S., Li, J., Lin, Y., Deng, Y., Li, N., Guo, Y., Yu, P., et al. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.07.081 · Cited by 58
Barone, E., Head, E., Butterfield, D. A., & Perluigi, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.508 · Cited by 53
Self-citationCorrales, A., Vidal, R., García, S., Vidal, V., Martínez, P., García, E., Flórez, J., Sanchez‐Barceló, E. J., Martínez‐Cué, C., & Rueda, N. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12097 · Cited by 51
Pathways to cognitive deficits in Down syndrome
Sturgeon, X., Le, T., Ahmed, M. M., & Gardiner, K. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00005-4 · Cited by 59
Tramutola, A., Di Domenico, F., Barone, E., Arena, A., Giorgi, A., di Francesco, L., Schininà, M. E., Coccia, R., Head, E., Butterfield, D. A., et al. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6686 · Cited by 49
“Several studies have demonstrated that elevated oxidative stress is already present in fetal DS brain (51, 56, 75) and in the amniotic fluid collected from women carrying a fetus with DS (58).”
BackgroundSelf-citationLanzillotta, C., Tramutola, A., Di Giacomo, G., Marini, F., Butterfield, D. A., Di Domenico, F., Perluigi, M., & Barone, E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.042 · Cited by 47
Self-citationLanzillotta, C., Zuliani, I., Tramutola, A., Barone, E., Blarzino, C., Folgiero, V., Caforio, M., Valentini, D., Villani, A., Locatelli, F., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101892 · Cited by 44
Self-citationCho, C.-K. J., Drabovich, A. P., Batruch, I., & Diamandis, E. P. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.025 · Cited by 42
“[10] Perluigi M, di Domenico F, Fiorini A, Cocciolo A, Giorgi A, Foppoli C, et al.”
BackgroundRedox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Kovacic, P., & Somanathan, R. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499429 · Cited by 41
Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Kovacic, P., & Somanathan, R. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143487 · Cited by 52
Parisotto, E. B., Vidal, V., García-Cerro, S., Lantigua, S., Wilhelm Filho, D., Sanchez-Barceló, E. J., Martínez-Cué, C., & Rueda, N. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2008-8 · Cited by 37
“neurogenesis and differentiation, connection and survival [6-8].”
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules
Lanzillotta, C., & Domenico, F. D. (2021) · Biomolecules · doi:10.3390/biom11020266 · Cited by 38
“3-nitrotyrosine in the cytoplasm of cerebral neurons in DS [85], an increase of protein carbonyls in peripheral blood mononucleate cells from children with DS [59], and the escalation of protein oxidation in the amniotic fluid from mothers carrying a DS fetus [82].”
BackgroundCellular senescence and premature aging in Down Syndrome
Peng, L., Baradar, A. A., Aguado, J., & Wolvetang, E. J. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111824 · Cited by 38
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
Rueda Revilla, N., & Martínez-Cué, C. (2020) · Antioxidants · doi:10.3390/antiox9080692 · Cited by 35
“In DS, it has been demonstrated that beginning at early developmental stages, there are important mitochondrial structural and functional dysfunctions associated with high ROS production [22,23] due to the excessive generation of O2− and H2O2.”
BackgroundAtlante, A., & Valenti, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050283 · Cited by 39
Guedj, F., Siegel, A. E., Pennings, J. L. A., Alsebaa, F., Massingham, L. J., Tantravahi, U., & Bianchi, D. W. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.10.001 · Cited by 33
The identification of protein biomarkers for oxidative stress in Down syndrome
Perluigi, M., & Butterfield, D. A. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.36 · Cited by 29
Self-citationTranslational validity and implications of pharmacotherapies in preclinical models of Down syndrome
Rueda, N., Flórez, J., Dierssen, M., & Martínez‐Cué, C. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.001 · Cited by 31
Yuan, Y., Zhang, L., Jin, L., Liu, J., Li, Z., Wang, L., & Ren, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.014 · Cited by 29
“Maternal exposure to environmental pollutants [4–6,46] and antiepileptic drugs and maternal diabetes/hyperglycemia and obesity are associated with elevated risk of NTDs.”
BackgroundLiu, X., Song, Y., Guo, Z., Sun, W., & Liu, J. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.04.023 · Cited by 27
Moreira‐Filho, C. A., Bando, S. Y., Bertonha, F. B., Silva, F. N., Costa, L. D. F., Ferreira, L., Furlanetto, G., Chaccur, P., Zerbini, M. C. N., & Carneiro-Sampaio, M. M. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7120 · Cited by 23
“This is quite understandable considering that oxidative damage is an early event (detected in DS pregnancy) in the DS pathogenesis and might contribute to the development of deleterious DS phenotypes [246].”
Smoking and its association with cryptorchidism in Down syndrome
Duarte, A. M. B. D. R., de Bessa, J., Mrad, F. C. D. C., Tibiriçá, S. H. C., Camargo, M. L. D. S., Vieira, A. A. P., Araujo, F. C. C., de Figueiredo, A. A., & Bastos-Netto, J. M. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.08.693 · Cited by 22
Butterfield, D. A., Boyd-Kimball, D., & Reed, T. T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0214 · Cited by 24
“Oxidative stress is an early event in DS (Butterfield et al, 2014; Cenini et al, 2012; Perluigi et al, 2011); thus, this model allowed for testing of the antioxidant effects of VP961.”
Self-citationSerum proteomics in patients with diagnosis of abdominal aortic aneurysm
Spadaccio, C., Domenico, F. D., Marzia Perluigi, A., Lusini, M., Giorgi, A., Schininà, M. E., Blarzino, C., Covino, E., Chello, M., & Coccia, R. (2011) · Cardiovascular Pathology · doi:10.1016/j.carpath.2011.09.008 · Cited by 22
“Serum sample (5 ml) was precipitated in acetone (1:3) overnight at −20°C, as previously described [10].”
MethodSelf-citationCorrales, A., Parisotto, E. B., Vidal, V., García-Cerro, S., Lantigua, S., Diego, M., Filho, D. W., Sánchez‐Barceló, E. J., Martínez‐Cué, C., & Rueda, N. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.022 · Cited by 23
The Role of Oxidative Stress in Trisomy 21 Phenotype
Buczyńska, A., Sidorkiewicz, I., Kretowski, A. J., & Zbucka-Krętowska, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01417-6 · Cited by 21
“These processes have been implicated in the DS phenotype, providing insights into the role of oxi‑ dative stress in T21 pathogenesis (Perluigi et al. 2011; Zis et al., n.d.; Slonim et al. 2009; Marcovecchio et al. 2021; Convertini et al. 2016).”
BackgroundInfluentialGuerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 21
Role of metal ions in the cognitive decline of Down syndrome
Malakooti, N., Pritchard, M. A., Adlard, P. A., & Finkelstein, D. I. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00136 · Cited by 23
“The increased level of Tf is also evident in the amniotic fluid obtained from women carrying DS foetuses (Perluigi et al., 2011), suggesting iron-mediated damage starts during pregnancy.”
BackgroundPost-translational quantitation by SRM/MRM: applications in cardiology
Gianazza, E., & Banfi, C. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1484283 · Cited by 21
2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome
Heywood, W., Madgett, T. E., Wang, D., Wallington, A., Hogg, J., Mills, K. A., & Avent, N. D. (2011) · Proteome Science · doi:10.1186/1477-5956-9-56 · Cited by 18
“of mass spectrometric methods, has been used in several studies to define new potential biomarkers for aneuploid pregnancies [11,12,16-20].”
BackgroundMethodInfluentialPreliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum
Yu, B., Zhang, B., Wang, J., Wang, Q., Huang, R.-P., Yang, Y., & Shao, S. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011312 · Cited by 18
Oxidative stress biomarkers in amniotic fluid of pregnant women with hypothyroidism
Novakovic, T. R., Dolicanin, Z. C., & Djordjević, N. Z. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1400005 · Cited by 19
Hsu, T., Lin, H., Hung, H.-N., Yang, K. D., Ou, C., Tsai, C., Cheng, H.-H., Chung, S.-H., Cheng, B., Wong, Y.-H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145908 · Cited by 17
“Perluigi M et al pointed out that AF ApoA1 increase oxidative damage is an early event in the DS pathogenesis and might contribute to the development of deleterious DS phenotypes [17].”
BackgroundIncreased risk of leukaemia in children with Down syndrome: a somatic evolutionary view
Hasaart, K., Bertrums, E. J. M., Manders, F., Goemans, B. F., & van Boxtel, R. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.6 · Cited by 20
Yao, Y., Liao, Y., Han, M., Li, S., Luo, J., & Zhang, B. (2016) · Scientific Reports · doi:10.1038/srep18866 · Cited by 17
Mitochondrial Imbalance in Down Syndrome: A Driver of Accelerated Brain Aging?
Zuo, X. (2025) · Aging and Disease · doi:10.14336/ad.2025.0189 · Cited by 19
“In DS, elevated oxidative biomarkers, including protein carbonylation, lipid peroxidation, and antioxidant system impairment, have been identified in the amniotic fluid of DS fetuses, underscoring mitochondrial dysfunction and oxidative stress as key contributors to DS pathogenesis [42].”
Triplication of HSA21 on alterations in structure and function of mitochondria
Ganguly, B. B., & Kadam, N. N. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.05.007 · Cited by 16
Lanzillotta, S., Esteve, D., Lanzillotta, C., Tramutola, A., Lloret, A., Forte, E., Pesce, V., Picca, A., Domenico, F. D., Perluigi, M., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.043 · Cited by 15
Puente-Bedia, A., Berciano, M. T., Martínez‐Cué, C., Lafarga, M., & Rueda, N. (2022) · Antioxidants · doi:10.3390/antiox11122438 · Cited by 14
“Thus, increased OS in the DS brain is an early event that negatively affects brain development, but, during later life stages, OS in DS is further aggravated [23,33].”
BackgroundProtein Oxidation in the Lungs of C57BL/6J Mice Following X-Irradiation
Barshishat-Küpper, M., McCart, E. A., Freedy, J. G., Tipton, A. J., Nagy, V., Kim, S.-Y., Landauer, M. R., Mueller, G. P., & Day, R. M. (2015) · Proteomes · doi:10.3390/proteomes3030249 · Cited by 13
“apolipoprotein A1 was identified in the amniotic fluid of women carrying Down syndrome fetuses, providing evidence that oxidative stress is an early characteristic of Down syndrome [65].”
BackgroundBuczyńska, A., Malinowski, P., Żbikowski, A., Kretowski, A. J., & Zbucka-Krętowska, M. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1577044 · Cited by 12
“Perluigi et al. (2011) Our previous research also demonstrated a significant increase in DNA/RNA OSDP levels in amniotic fluid samples among pregnancies affected by T21 compared to euploid samples (Buczyńska et al., 2021a).”
InfluentialShan, D., Wang, H., Khatri, P., Niu, Y., Song, W., Zhao, S., Jiang, Y., Ma, Q., Liu, X., Zhang, R., et al. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0098 · Cited by 11
“This finding could be strongly supported by the known evidence that oxidative stress occurs early in fetal Down’s syndrome (Perluigi et al., 2011).”
Reisz, J. A., Barrett, A. S., Nemkov, T. G., Hansen, K. C., & D’Alessandro, A. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1453362 · Cited by 11
“stress occurs early in life and can even be detected in the amniotic fluid of a DS pregnancy [238].”
BackgroundAntioxidant Effects of Potassium Ascorbate with Ribose Therapy in a Case with Prader Willi Syndrome
Anichini, C., Lotti, F., Longini, M., Proietti, F., Felici, C., Perrone, S., & Buonocore, G. (2012) · Disease Markers · doi:10.1155/2012/425205 · Cited by 12
Oxidative Stress and Down Syndrome: A Systematic Review
Slivšek, G., Mijač, S., Dolanc, I., Fabijanec, M., Petković, S., Mautner, R., Lončarek, K., Kranjčić, J., Blagaić, A. B., Marinović, M., et al. (2025) · Antioxidants · doi:10.3390/antiox14070816 · Cited by 10
“This emphasises the hypothesis of early onset and accumulation of oxidative damage that may have clinical implications for life after birth [47,79,91,92].”
Proteomics advancements in fetomaternal medicine
Anagnostopoulos, A. K., & Tsangaris, G. T. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.10.011 · Cited by 9
“The specific study consisted of slot-blots, western blots, enzymatic assays and redox proteomics analyses, which showed that oxidative damage is an early event in DS pathogenesis and might contribute to the development of deleterious DS phenotypes, including abnormal development and AD-like neuropathology [36].”
BackgroundAlasmari, F. F., Ahmad, A., Alsanea, S., Hammad, A. M., & Al-Qerem, W. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1592277 · Cited by 9
Antioxidant effects of potassium ascorbate with ribose in costello syndrome.
Anichini, C., Lotti, F., Pietrini, A., Rizzo, C. L., Longini, M., Proietti, F., Felici, C., & Buonocore, G. (2013) · PubMed · Cited by 9
Yao, Y., Jiang, Y., Han, M., Xia, Y., He, Y., Wang, Y., Luo, Y., & Zhang, B. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2015.979796 · Cited by 7
“It was shown that chronic oxidative stress injury might be a risk factor for neurodegeneration in DS-affected subjects [31] and conduced to the development of DS phenotypes [39].”
BackgroundDomenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_23 · Cited by 7
Self-citationSeth, E. A., Lee, H.-C., Yusof, H. H. M., Nordin, N., Cheah, Y. K., Ho, E. T. W., Ling, K., & Cheah, P.-S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236826 · Cited by 6
“Accumulating evidence has shown that increased oxidative stress contributes to the cognitive phenotypes observed in DS, and that it may occur at an early stage [51,52].”
BackgroundFuture Perspectives in Oxidative Stress in Trisomy 13 and 18 Evaluation
Buczyńska, A., Sidorkiewicz, I., Hameed, A., Kretowski, A. J., & Zbucka-Krętowska, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071787 · Cited by 5
“Moreover, the dysregulated ApoA1 expression could also correspond to the oxidative damage observed in trisomy 21-based studies [22,54].”
BackgroundAzodi, M. Z., Rezaei–Tavirani, M., Tavirani, M. R., & Rostami‐Nejad, M. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.12.1.941.6 · Cited by 4
“One of the identified novel processes related to the DS mechanism was the oxidative stress process, which was repeatedly pinpointed by many proteomic studies (Butterfield, Di Domenico, Tramutola, Head, & Perluigi, 2017; Di Domenico et al., 2014; Perluigi et al., 2011).”
BackgroundYu, B., Zhang, B., Shi, Y., Shao, S., Wang, Q., Huang, R.-P., & Yang, Y. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.28543 · Cited by 4
“[32] found that oxidative damage is an early event in DS pathogenesis and might contribute to the development of deleterious DS phenotypes.”
BackgroundMusladin-Lueke Syndrome in a Dog: Case Report
Carneiro, R. K., Gatti, G. T., Beck, R. C., Amadori, A., Oliveira, T. D., Feliciano, M. A. R., Alievi, M. M., & Ferreira, M. P. (2022) · Topics in companion animal medicine · doi:10.1016/j.tcam.2022.100694 · Cited by 1
Non-Invasive Prenatal Screening for Down Syndrome: A Review of Mass-Spectrometry-Based Approaches
Jurca, R. L., Pralea, I.-E., Iacobescu, M., Rus, I., Iuga, C. A., & Stamatian, F. V. (2025) · Life · doi:10.3390/life15050695 · Cited by 1
“In context of T21, there were several studies implementing methodologies for biomarker confirmation, ELISA or bead-based multiplexed immunoas-says [36,37,40], or directed to assays developed for biomarker quantitation, LC-MS/MS and SRM assays [34,35,38], from various biological matrices.”
Swanson, E. C. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2k30f · Cited by 1
“However, oxidative stress is not just a problem exclusive to later in life, as increased levels of oxidative stress have been found in utero of DS fetuses and in young DS mouse models (Ishihara et al., 2009; Perluigi et al., 2011; Perrone et al., 2007; Slonim et al., 2009).”
BackgroundFrancisco, J., Díaz, A. J., Rosety, I., & García, N. (2012)
Down Syndrome as a Special Case of Oxidatively Induced Developmental Dysregulation
Marzia Perluigi, A., & Butterfield, D. A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-1405-0_7
Self-citationFazal, Y., Zohaib, M., Hashim, Z., Ansari, S. H., & Zarina, S. (2020) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2020.1725940
“It was suggested that oxidative stress may not only result in abnormal development of the fetus but can also be linked with characteristic traits of DS development [32].”
BackgroundTriplicated HSA21 genes and mtDNA on mitochondrial dysfunction
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00012-0
Alzheimer disease and neuroinflammation in Down syndrome
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00014-4
Investigating the Origins of Biochemical Dysregulation in Trisomy 21 Pregnancy
Buczyńska, A., Sidorkiewicz, I., Kretowski, A. J., & Zbucka-Krętowska, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf339
Are Bioimpedance Parameters Altered in Adults With Down Syndrome? A Cross‐Sectional Study
Silva, A. D. A. C. E., Carbó‐Carreté, M., Javierre, C. F., Guàrdia‐Olmos, J., Agiovlasitis, S., & Oviedo, G. R. (2026) · Journal of Intellectual Disability Research · doi:10.1111/jir.70143
Metadata
- Authors
- Perluigi, M., di Domenico, F., Fiorini, A., Cocciolo, A., Giorgi, A., Foppoli, C., Butterfield, D. A., Giorlandino, M., Giorlandino, C., Eugenia Schininà, M., & Coccia, R.
- Affiliations
- Sapienza University of Rome (IT)
- Institute of Molecular Biology and Pathology (IT)
- University of Kentucky (US)
- Altamedica Artemisia (IT)
- Corresponding author
- Butterfield, D. Allan
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2011-02-24
- Volume
- 5
- Issue
- 3-4
- Pages
- 167-178
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2069717482
- Cited by
- 97
- References
- 75
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 10 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 5 · 2014: 9 · 2013: 6 · 2012: 10
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PROTEOMICS - CLINICAL APPLICATIONS (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Artemisia Medical Center of Rome
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- Down syndrome, oxidative stress, amniotic fluid, protein carbonylation, glutathione, thioredoxin, heat shock proteins, redox proteomics, lipid peroxidation, iron homeostasis, ceruloplasmin, zinc-alpha2-glycoprotein, retinol-binding protein 4, apolipoprotein A-I, complement C9, alpha-1B-glycoprotein, early pregnancy
- MeSH terms
- Adult, Amniotic Fluid, Down Syndrome, Female, Humans, Oxidation-Reduction, Phenotype, Pregnancy, Pregnancy Trimester, First, Proteins, Retrospective Studies, Sensitivity and Specificity, Oxidative Stress, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.